Serum transgelin is a novel prognostic biomarker for COVID-19 patients
The expression of serum transgelin is positively with the severity and poorly prognostic outcomes among COVID-19 patients, indicating that transgelin is implicated in the pathological process of COVID-19. Transgelin can assist in the risk stratification and revealing the pathological mechanisms of COVID-19.
Authors
- Lei Gao (ORCID: https://orcid.org/0000-0001-7505-3914)
- Hui Zhao (ORCID: https://orcid.org/0000-0003-4090-5720)
- Qi-Yuan He (ORCID: https://orcid.org/0009-0004-2181-6882)
- Ya‐Lin Jiang
- Ying Liu (ORCID: https://orcid.org/0000-0003-2408-3712)
- Jin Yang (ORCID: https://orcid.org/0000-0003-2008-7089)
- Lin Fu
- Yu Wang (ORCID: https://orcid.org/0009-0005-0661-311X)
Institutions
- Anhui Medical University (CN)
- Bozhou People's Hospital (CN)
- Second Affiliated Hospital of Anhui Medical University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2024-11-29
- DOI
- https://doi.org/10.3389/fimmu.2024.1423182
- Primary Topic
- Pancreatitis Pathology and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Anhui Medical University